Cytokinetics Inc: evp r&d Malik Fady Ibraham exercised 3,500 shares

What happened

• Malik Fady Ibraham, evp research & development, exercised options for 3,500 shares at $7.80 per share (acquired for $27,300) and sold 3,500 shares at $61.38 per share (disposed for $214,830) on Oct 6, 2026. The filing also reports a derivative disposition of 3,500 shares at $0.00 on the same date.

Key details

• Transaction date and prices: Oct 6, 2026 — exercised 3,500 shares @ $7.80 (acquired, $27,300); sold 3,500 shares @ $61.38 (disposed, $214,830); derivative disposition 3,500 @ $0.00.
• Shares owned after the transaction: not reported in this filing.
• Footnotes/plans: the filing does not disclose any 10b5-1 plan, tax-withholding disposition, or other footnote details in the summary provided.
• Filing timeliness: filed on Oct 6, 2026; the filing does not indicate it was late.

Why it may matter

• The filing shows an option exercise and the same number of shares were sold on the same date, i.e., the exercised shares were sold the same day.
• For derivative transactions the filing reports an exercise and a derivative disposition on Oct 6, 2026.
• A filing does not show why the insider traded or why the company acted.